STATE STREET CORP - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 139 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$12,484,283
-79.1%
3,052,392
-19.4%
0.00%
-66.7%
Q1 2024$59,661,876
-10.8%
3,785,652
-14.3%
0.00%0.0%
Q4 2023$66,918,398
+23.4%
4,417,056
+63.4%
0.00%0.0%
Q3 2023$54,229,402
-39.0%
2,703,360
-14.3%
0.00%
-40.0%
Q2 2023$88,943,704
+82.6%
3,152,914
+11.3%
0.01%
+66.7%
Q1 2023$48,710,796
-60.8%
2,832,023
-54.1%
0.00%
-25.0%
Q4 2022$124,229,038
+101.2%
6,168,274
+116.4%
0.00%0.0%
Q3 2022$61,735,000
-29.6%
2,850,174
-8.6%
0.00%
-20.0%
Q2 2022$87,665,000
-8.7%
3,119,734
+50.0%
0.01%0.0%
Q1 2022$95,992,000
-15.2%
2,080,440
+54.5%
0.01%0.0%
Q4 2021$113,180,000
+31.4%
1,346,416
+4.2%
0.01%0.0%
Q3 2021$86,116,000
+20.9%
1,292,263
-3.5%
0.01%
+25.0%
Q2 2021$71,253,000
+11.8%
1,339,340
-8.8%
0.00%0.0%
Q1 2021$63,748,000
+37.7%
1,469,191
+64.8%
0.00%
+33.3%
Q4 2020$46,305,000
+776.5%
891,509
+451.7%
0.00%
Q3 2020$5,283,000
-19.9%
161,594
+17.7%
0.00%
Q2 2020$6,592,000137,2700.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q1 2024
NameSharesValueWeighting ↓
Mayo Clinic 187,143$765,41525.27%
Decheng Capital LLC 3,070,442$12,558,1073.85%
MPM BioImpact LLC 1,450,000$5,930,5000.92%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 961,486$3,932,4780.80%
Eventide Asset Management 8,547,896$34,960,8950.60%
5AM Venture Management, LLC 490,000$2,004,1000.45%
Matrix Capital Management Company, LP 13,959,973$57,096,2900.44%
Values First Advisors, Inc. 74,925$306,4430.18%
Boxer Capital, LLC 450,000$1,840,5000.10%
GSA CAPITAL PARTNERS LLP 255,201$1,0440.07%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders